• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂 1 的免疫反应性及其与子宫腺肌病痛经和病灶纤维化的关系。

Immunoreactivity of Plasminogen Activator Inhibitor 1 and Its Correlation with Dysmenorrhea and Lesional Fibrosis in Adenomyosis.

机构信息

International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, NO. 910, Heng-Shan Road, Xu-Hui Qu, Shanghai, 200030, China.

Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, 200030, China.

出版信息

Reprod Sci. 2021 Aug;28(8):2378-2386. doi: 10.1007/s43032-021-00513-6. Epub 2021 Mar 8.

DOI:10.1007/s43032-021-00513-6
PMID:33683668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8289782/
Abstract

Adenomyosis is associated with dysmenorrhea, infertility, and lesional fibrosis. The pathogenesis of adenomyosis is still unclear. Plasminogen activator inhibitor 1 (PAI-1) plays important roles in pathological activities like tumor metastasis and endometriosis. Our objective was to investigate the expression and localization of PAI-1 in eutopic and ectopic endometrium with adenomyosis and in endometrium without adenomyosis. We also sought to determine the relationship between PAI-1 immunoreactivity and the severity of dysmenorrhea and the extent of lesional fibrosis in adenomyosis. PAI-1 expression was significantly higher in the ectopic endometrium of patients with adenomyosis than in both the eutopic endometrium of patients with adenomyosis and the endometrium of controls. Ectopic PAI-1 expression correlated positively with dysmenorrhea visual analog scale (VAS) scores and the extent of lesional fibrosis in adenomyosis. High PAI-1 expression increased the likelihood of moderate to severe dysmenorrhea in adenomyosis. These results suggest that PAI-1 is involved in the adenomyosis-associated dysmenorrhea and lesional fibrosis, which provide a potential target in treating symptomatic adenomyosis.

摘要

子宫腺肌病与痛经、不孕和病灶纤维化有关。其发病机制尚不清楚。纤溶酶原激活物抑制剂 1(PAI-1)在肿瘤转移和子宫内膜异位症等病理活动中发挥重要作用。我们的目的是研究 PAI-1 在伴有和不伴有子宫腺肌病的异位和在位子宫内膜中的表达和定位,并探讨 PAI-1 免疫反应性与痛经严重程度和子宫腺肌病病灶纤维化程度之间的关系。子宫腺肌病患者的异位子宫内膜中 PAI-1 的表达明显高于子宫腺肌病患者的在位子宫内膜和对照组的子宫内膜。异位 PAI-1 的表达与痛经视觉模拟评分(VAS)呈正相关,也与子宫腺肌病病灶纤维化的程度相关。高 PAI-1 表达增加了子宫腺肌病中度至重度痛经的可能性。这些结果表明,PAI-1 参与了与子宫腺肌病相关的痛经和病灶纤维化,为治疗有症状的子宫腺肌病提供了一个潜在的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e83/8289782/7b6dc906515f/43032_2021_513_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e83/8289782/c386d8422897/43032_2021_513_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e83/8289782/7b6dc906515f/43032_2021_513_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e83/8289782/c386d8422897/43032_2021_513_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e83/8289782/7b6dc906515f/43032_2021_513_Fig2_HTML.jpg

相似文献

1
Immunoreactivity of Plasminogen Activator Inhibitor 1 and Its Correlation with Dysmenorrhea and Lesional Fibrosis in Adenomyosis.纤溶酶原激活物抑制剂 1 的免疫反应性及其与子宫腺肌病痛经和病灶纤维化的关系。
Reprod Sci. 2021 Aug;28(8):2378-2386. doi: 10.1007/s43032-021-00513-6. Epub 2021 Mar 8.
2
Expression of annexin A2 in adenomyosis and dysmenorrhea. Annexin A2 在子宫腺肌病和痛经中的表达。
Arch Gynecol Obstet. 2019 Sep;300(3):711-716. doi: 10.1007/s00404-019-05205-w. Epub 2019 Jun 10.
3
The expression and functionality of stromal caveolin 1 in human adenomyosis.基质 Cav-1 在人子宫腺肌病中的表达和功能。
Hum Reprod. 2013 May;28(5):1324-38. doi: 10.1093/humrep/det042. Epub 2013 Feb 26.
4
Decreased expression of cell polarity protein Scribble correlated with altered subcellular localization of the Crumbs homologue 3 protein in human adenomyotic endometrial cells.细胞极性蛋白Scribble表达降低与人类子宫腺肌病子宫内膜细胞中Crumb同源物3蛋白的亚细胞定位改变相关。
J Obstet Gynaecol Res. 2019 Jun;45(6):1148-1159. doi: 10.1111/jog.13952. Epub 2019 Mar 25.
5
Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis.催产素受体和瞬时受体电位香草酸 1 型的免疫反应性及其与子宫腺肌病痛经的相关性。
Am J Obstet Gynecol. 2010 Apr;202(4):346.e1-8. doi: 10.1016/j.ajog.2009.11.035. Epub 2010 Jan 22.
6
Expression of CD56 in patients with adenomyosis and its correlation with dysmenorrhea.子宫腺肌病患者CD56的表达及其与痛经的相关性。
Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:101-5. doi: 10.1016/j.ejogrb.2015.08.027. Epub 2015 Aug 28.
7
[Expression of nerve growth factor produced by ectopic endometrium from patients with adenomyosis and its relationship with pain scales and innervation].[子宫腺肌病患者异位内膜产生的神经生长因子表达及其与疼痛评分和神经支配的关系]
Zhonghua Fu Chan Ke Za Zhi. 2014 Feb;49(2):120-4.
8
Correlation between Cyr61 expression and clinicopathologic parameters in adenomyosis.子宫腺肌病中Cyr61表达与临床病理参数的相关性
J Reprod Immunol. 2016 Nov;118:42-49. doi: 10.1016/j.jri.2016.08.004. Epub 2016 Aug 17.
9
Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis.组织因子免疫反应升高与子宫腺肌病痛经严重程度和经血量的关系。
Hum Reprod. 2011 Feb;26(2):337-45. doi: 10.1093/humrep/deq311. Epub 2010 Nov 28.
10
Increased immunoreactivity to SLIT/ROBO1 and its correlation with severity of dysmenorrhea in adenomyosis.SLIT/ROBO1 免疫反应增强及其与子宫腺肌病痛经严重程度的相关性。
Fertil Steril. 2011 Mar 1;95(3):1164-7. doi: 10.1016/j.fertnstert.2010.09.027.

引用本文的文献

1
Exosomal miR-92a-3p serves as a promising marker and potential therapeutic target for adenomyosis.外泌体miR-92a-3p作为子宫腺肌病的一个有前景的标志物和潜在治疗靶点。
Sci Rep. 2025 Mar 22;15(1):9928. doi: 10.1038/s41598-024-84608-5.
2
Adenomyosis and Abnormal Uterine Bleeding: Review of the Evidence.子宫腺肌病和异常子宫出血:证据综述。
Biomolecules. 2024 May 23;14(6):616. doi: 10.3390/biom14060616.
3
CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis.子宫腺肌病患者中CA125相关的活化部分凝血活酶时间及凝血酶时间降低

本文引用的文献

1
Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis.雌激素受体-α免疫反应可预测深部子宫内膜异位症的症状严重程度和疼痛复发。
Fertil Steril. 2020 Jun;113(6):1224-1231.e1. doi: 10.1016/j.fertnstert.2020.01.036. Epub 2020 May 13.
2
Evidence in Support for the Progressive Nature of Ovarian Endometriomas.支持卵巢子宫内膜异位症进行性特征的证据。
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa189.
3
Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment.
J Multidiscip Healthc. 2024 Jan 16;17:251-261. doi: 10.2147/JMDH.S435365. eCollection 2024.
4
Application of elastography to diagnose adenomyosis and evaluate the degree of dysmenorrhea: a prospective observational study.弹性成像技术在诊断子宫腺肌病及评估痛经程度中的应用:一项前瞻性观察性研究。
Reprod Biol Endocrinol. 2023 Oct 26;21(1):98. doi: 10.1186/s12958-023-01145-y.
5
The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study.凝血因子对子宫内膜异位症风险的影响:一项孟德尔随机化研究。
BMC Med. 2023 May 25;21(1):195. doi: 10.1186/s12916-023-02881-z.
6
Role of ultrasonography in the evaluation of disease severity and treatment efficacy in adenomyosis.超声检查在子宫腺肌病严重程度评估及疗效评价中的作用。
Arch Gynecol Obstet. 2024 Feb;309(2):363-371. doi: 10.1007/s00404-023-07034-4. Epub 2023 Apr 28.
7
The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis.血小板在子宫腺肌病发病机制和病理生理学中的作用
J Clin Med. 2023 Jan 20;12(3):842. doi: 10.3390/jcm12030842.
8
The Menstrual Endometrium: From Physiology to Future Treatments.月经子宫内膜:从生理到未来治疗
Front Reprod Health. 2022 Jan 31;3:794352. doi: 10.3389/frph.2021.794352. eCollection 2021.
9
Hypo-Expression of Tuberin Promotes Adenomyosis the mTOR1-Autophagy Axis.结节性硬化蛋白低表达通过mTOR1-自噬轴促进子宫腺肌病
Front Cell Dev Biol. 2021 Jul 29;9:710407. doi: 10.3389/fcell.2021.710407. eCollection 2021.
低抗苗勒管激素水平不是 IVF/ICSI 治疗中早期妊娠丢失的危险因素。
Hum Reprod. 2020 Mar 27;35(3):504-515. doi: 10.1093/humrep/deaa008.
4
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis.子宫腺肌病与子宫内膜异位症的发病机制
J Clin Med. 2020 Feb 10;9(2):485. doi: 10.3390/jcm9020485.
5
Classification and Reporting Systems for Adenomyosis.子宫腺肌病的分类和报告系统。
J Minim Invasive Gynecol. 2020 Feb;27(2):296-308. doi: 10.1016/j.jmig.2019.11.013. Epub 2019 Nov 27.
6
Transcriptome sequencing of adenomyosis eutopic endometrium: A new insight into its pathophysiology.子宫腺肌病在位子宫内膜的转录组测序:对其病理生理学的新认识。
J Cell Mol Med. 2019 Dec;23(12):8381-8391. doi: 10.1111/jcmm.14718. Epub 2019 Oct 1.
7
Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis.纤溶酶原激活物抑制剂-1(PAI-1)在子宫内膜异位症中的表达。
PLoS One. 2019 Jul 17;14(7):e0219064. doi: 10.1371/journal.pone.0219064. eCollection 2019.
8
Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity.子宫息肉、子宫腺肌病、子宫肌瘤和子宫内膜容受性。
Fertil Steril. 2019 Apr;111(4):629-640. doi: 10.1016/j.fertnstert.2019.02.008.
9
Genesis, genes and epigenetics of endometriosis-associated infertility.子宫内膜异位症相关性不孕的起源、基因与表观遗传学
Nat Rev Endocrinol. 2019 May;15(5):259-260. doi: 10.1038/s41574-019-0191-9.
10
Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis.神经肽 P 物质和降钙素基因相关肽加速子宫内膜异位症的发生和纤维化。
Sci Rep. 2019 Feb 25;9(1):2698. doi: 10.1038/s41598-019-39170-w.